Skip to main content
. 2023 Aug 18;11(8):2295. doi: 10.3390/biomedicines11082295

Table 1.

Demography, clinical characteristics, and body composition of study population.

Normal-Weight Subjects Obese Subjects p
Age (years) 13.1 ± 0.16 12.2 ± 0.36 ns
Male:Female 9:11 18:12 ns
Pubertal Stage (Tanner score) 3.1 ± 0.18 3.6 ± 0.143 0.0461
Height (cm) 157.4 ± 0.96 155.4 ± 2.34 ns
Height z-score 0.22 ± 0.06 0.91 ± 0.2 0.0086
Weight (Kg) 50.3 ± 0.79 72.7 ± 3.1 <0.0001
BMI 20.2 ± 0.20 29.8 ± 0.79 <0.0001
BMI z-score 0.68 ± 0.08 2.91 ± 0.2 <0.0001
WC (cm) 84.3 ± 2.1 92.1 ± 1.78 0.0093
Fat Mass (%) 19.7 ± 1.51 36.7 ± 1.78 <0.0001
SBP (mmHg) 112.5 ± 1.8 108.0 ± 2.2 ns
DBP (mmHg) 62.2 ± 1.4 63.8 ± 1.7 ns
HOMA-IR 0.95 ± 0.09 2.5 ± 0.24 <0.0001

Table Legend: All data are expressed as mean ± SEM. BMI: Body Mass Index; WC: Waist Circumference; SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure; HOMA-IR: HOmeostatic Model Assessment of Insulin Resistance; ns: not significant.